These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19859990)

  • 1. Hepatitis C comorbidities affecting the course and response to therapy.
    El-Zayadi AR
    World J Gastroenterol; 2009 Oct; 15(40):4993-9. PubMed ID: 19859990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C?
    Alberti A
    Liver Int; 2009 Jan; 29 Suppl 1():15-8. PubMed ID: 19207961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of iron overload and HFE gene mutations in the era of pegylated interferon and ribavirin treatment of chronic hepatitis C.
    Sikorska K; Stalke P; Izycka-Swieszewska E; Romanowski T; Bielawski KP
    Med Sci Monit; 2010 Mar; 16(3):CR137-143. PubMed ID: 20190684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C.
    Hauser G; Awad T; Brok J; Thorlund K; Štimac D; Mabrouk M; Gluud C; Gluud LL
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD005441. PubMed ID: 24585509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis, treatment, and follow-up of hepatitis C-virus related liver disease. Hungarian national consensus guideline].
    Hunyady B; Gervain J; Horváth G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I
    Orv Hetil; 2014 Mar; 155 Suppl():3-24. PubMed ID: 24631886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for dialysis patients with hepatitis C virus (HCV) infection.
    Prabhu RA; Nair S; Pai G; Reddy NP; Suvarna D
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007003. PubMed ID: 26287983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multidisciplinary support programme increases the efficiency of pegylated interferon alfa-2a and ribavirin in hepatitis C.
    Carrión JA; Gonzalez-Colominas E; García-Retortillo M; Cañete N; Cirera I; Coll S; Giménez MD; Márquez C; Martin-Escudero V; Castellví P; Navinés R; Castaño JR; Galeras JA; Salas E; Bory F; Martín-Santos R; Solà R
    J Hepatol; 2013 Nov; 59(5):926-33. PubMed ID: 23811030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Importance of adherence for efficacy of hepatitis C combined therapy].
    Nožić D; Delić D; Božić M; Fabri M; Svorcan P; Konstantinović L
    Srp Arh Celok Lek; 2013; 141(7-8):507-10. PubMed ID: 24073558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoadamantanes for chronic hepatitis C.
    Lamers MH; Broekman M; Drenth JP; Gluud C
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD010125. PubMed ID: 24793264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence.
    Bizollon T; Ahmed SN; Radenne S; Chevallier M; Chevallier P; Parvaz P; Guichard S; Ducerf C; Baulieux J; Zoulim F; Trepo C
    Gut; 2003 Feb; 52(2):283-7. PubMed ID: 12524414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experiences in antiviral treatment of chronic viral hepatitis B and C in Hungary (1998-2004)].
    Pár A; Tornai I; Szalay F
    Orv Hetil; 2007 May; 148(18):819-26. PubMed ID: 17468063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coinfection with hepatitis C virus and schistosomiasis: fibrosis and treatment response.
    Abdel-Rahman M; El-Sayed M; El Raziky M; Elsharkawy A; El-Akel W; Ghoneim H; Khattab H; Esmat G
    World J Gastroenterol; 2013 May; 19(17):2691-6. PubMed ID: 23674877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life and severity of fatigue in HIV/HCV co-infected patients before, during, and after antiviral therapy with pegylated interferon plus ribavirin.
    Mandorfer M; Payer BA; Scheiner B; Breitenecker F; Aichelburg MC; Grabmeier-Pfistershammer K; Rieger A; Trauner M; Peck-Radosavljevic M; Reiberger T
    Liver Int; 2014 Jan; 34(1):69-77. PubMed ID: 23890125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN.
    Alric L; Plaisier E; Thébault S; Péron JM; Rostaing L; Pourrat J; Ronco P; Piette JC; Cacoub P
    Am J Kidney Dis; 2004 Apr; 43(4):617-23. PubMed ID: 15042538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribavirin in the treatment of chronic hepatitis C.
    Martin P; Jensen DM
    J Gastroenterol Hepatol; 2008 Jun; 23(6):844-55. PubMed ID: 18565019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C advances in antiviral therapy: what is accepted treatment now?
    McHutchison JG
    J Gastroenterol Hepatol; 2002 Apr; 17(4):431-41. PubMed ID: 11982724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined antiviral options for the treatment of chronic hepatitis C.
    Medina J; García-Buey L; Moreno-Monteagudo JA; Trapero-Marugán M; Moreno-Otero R
    Antiviral Res; 2003 Oct; 60(2):135-43. PubMed ID: 14638410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peginterferon alfa-2b and ribavirin in thalassaemia/chronic hepatitis C virus-co-infected non-responder to standard interferon-based.
    Hamidah A; Thambidorai CR; Jamal R
    Med J Malaysia; 2005 Oct; 60(4):517-9. PubMed ID: 16570722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current treatment of hepatitis C virus infection].
    Lörke J; Avci A; Erhardt A; Heintges T; Häussinger D
    Dtsch Med Wochenschr; 2005 Jul; 130(30):1773-7. PubMed ID: 16049884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral regimen complexity index as an independent predictor of sustained virologic response in patients with chronic hepatitis C.
    Galán RJ; Cidoncha EC; Martin MF; Rodriguez CC; Almeida CV; Verdugo RM
    J Manag Care Pharm; 2013; 19(6):448-53. PubMed ID: 23806058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.